Watchdog says healthcare providers may be misrepresenting child gender treatments as routine care
Healthcare providers may be able to misrepresent transgender treatments for minors as routine care that is unrelated to gender-affirming treatments, a new report from medical watchdog Do No Harm revealed.
Chief medical officer at Do No Harm Dr. Kurt Miceli told The Center Square: “We suspect there are healthcare providers doing exactly what our report exposes: skirting coding rules to get paid for child sex changes.”
“Our report details how providers could potentially bypass coding guidelines and identifies eight likely diagnostic codes they would use,” Miceli said.
“To frame gender dysphoria as an endocrine disorder, for example, is simply wrong,” Miceli said.
“It undermines medical integrity, distorts diagnostic accuracy, and erodes public trust in how healthcare claims are coded and paid for – all of this before even considering the harms these experimental interventions inflict on vulnerable, gender-confused children,” Miceli said.
“Oversight is needed for providers who disregard systematic reviews showing very low evidence of benefit for these interventions and then sidestep coding rules to ensure they are reimbursed,” he said.
Do No Harm’s report revealed eight codes that may be used to misrepresent gender treatments for minors.
These codes are hypopituitarism, other primary ovarian failure, testicular hypofunction, precocious puberty, other specified endocrine disorders, endocrine disorder, unspecified, hormone replacement therapy, and hypertrophy of breast.
Do No Harm’s report stated that “there is significant evidence showing that many of the organizations involved in the child transgender industry have (at the very least) promoted alternative billing practices to secure insurance reimbursement.”
A press release from Do No Harm said that “by hiding transgender procedures behind codes meant for other conditions, providers are — at minimum — skirting guidelines and ethical standards.”
Latest News Stories
Illinois to regulate intoxicating hemp products, loosen up on cannabis
Nevada gubernatorial candidates clash over Trump’s policies
Feds cut funding for Hawaii Medicaid fraud unit
Two Democrats, two Republicans seek attorney general seat
Democrats condemn Minnesota GOP convention tribute to Derek Chauvin
Questions loom after data center legislation stalls
Feds charge 14 in Ohio fraud schemes, totaling $50M
U.S. Supreme Court rules in favor of generic drug patents
Former HHS secretary tied to company that could benefit from CMS screening proposal
Supreme Court rules against Verizon, AT&T over privacy penalties
Illinois quick hits: Stop child care scams act clears U.S. House, Illinois U.S. Reps introduce immigrant due process bill
Trump to tap Blanche as attorney general